BioCentury
ARTICLE | Financial News

Wex planning offering

December 1, 2009 12:59 AM UTC

Wex Pharmaceuticals Inc. (TSX:WXI) proposed late Friday to raise up to C$34.5 million ($32.7 million) through the sale of up to 265.5 million shares at C$0.13 in a rights offering. The price is a 32% discount to Wex's close of C$0.19 on Friday, before the deal was announced. Shareholders will be eligible to purchase one-and-a-half shares for each existing share held. ...